Maximus Gage
The Breo Ellipta inhaler is a prescription medicine used to treat asthma and chronic obstructive pulmonary disease (COPD). It contains two active ingredients: fluticasone furoate, an inhaled corticosteroid, and vilanterol trifenatate, a long-acting beta2-adrenergic agonist (LABA). Fluticasone helps to reduce inflammation in the lungs, while vilanterol relaxes the muscles around the airways, making it easier to breathe. While Breo Ellipta is generally well-tolerated, it can cause side effects such as a sore throat, upper respiratory tract infections, headaches, and oral candidiasis. More serious side effects may include an increased risk of pneumonia, heart-related issues such as an irregular heartbeat, and worsening of existing heart conditions. It is important to discuss the use of Breo Ellipta with a doctor, especially for those with a history of medical conditions, as it may not be suitable for everyone.
| Characteristics | Values |
|---|---|
| Purpose | To treat asthma or COPD (chronic obstructive pulmonary disease) |
| Function | Reduces inflammation and relaxes muscles around airways to improve breathing |
| Usage | Once-daily inhalation powder |
| Composition | Fluticasone (steroid) and vilanterol (bronchodilator) |
| Side Effects | Sore throat, common cold symptoms, upper respiratory tract infection, pneumonia, hoarseness, back pain, thrush, flu, muscle spasms, urinary tract infection, cough, sinusitis, diarrhoea |
| Precautions | Not for sudden COPD or asthma symptoms, not a rescue inhaler, may increase asthma-related problems, may weaken immune system |
| Interactions | Not to be used with other bronchodilators or specific medications without doctor's advice |
| Pregnancy and Breastfeeding | May not be safe, consult a doctor |
Explore related products
What You'll Learn
Breo Ellipta contains fluticasone and vilanterol
Breo Ellipta is a prescription medicine that combines fluticasone furoate, an inhaled corticosteroid (ICS), and vilanterol trifenatate, a long-acting beta2-adrenergic agonist (LABA). This combination of medicines helps improve lung function for a full 24 hours.
Fluticasone furoate, the ICS component, helps to decrease inflammation in the lungs. Inflammation in the lungs can lead to breathing problems. By reducing this inflammation, fluticasone improves airflow and makes it easier for individuals with asthma or COPD to breathe.
Vilanterol trifenatate, the LABA component, works by relaxing the muscles around the airways. This action opens up the lung airways, helping to prevent symptoms such as wheezing, coughing, chest tightness, and shortness of breath. Vilanterol, when used alone, may increase the risk of hospitalizations and death in people with asthma. However, when used in combination with fluticasone, this risk is not increased.
Breo Ellipta is a once-daily, long-term treatment for chronic obstructive pulmonary disease (COPD) and asthma in patients aged 5 years and older. It is important to note that Breo is not a rescue medicine and should not be used to treat sudden symptoms of asthma or COPD. Instead, it is meant to be used daily to prevent and manage symptoms.
Folic Acid: A Cause of Muscle Weakness?
You may want to see also
Explore related products
It is not a rescue medicine
The Breo Ellipta inhaler is not a rescue medicine and should not be used to treat sudden symptoms of asthma or COPD. It is a combination of two medicines: an inhaled corticosteroid (ICS) called fluticasone furoate, and a long-acting beta2-adrenergic agonist (LABA) called vilanterol. Fluticasone furoate helps to decrease inflammation in the lungs, which can lead to breathing problems. Vilanterol opens lung airways by relaxing the muscles around them and keeping them open, thus preventing symptoms such as wheezing, coughing, chest tightness, and shortness of breath.
Breo Ellipta is a prescription medicine used long-term to prevent and control symptoms of asthma and COPD for better breathing. It is approved for use in people aged 5 years and older with asthma. For COPD, it is approved for long-term management in adults. It is important to note that Breo Ellipta is not a substitute for a rescue inhaler and should not be used to treat sudden flare-ups or severe breathing difficulties. If you are experiencing a sudden worsening of symptoms, such as an asthma attack or a COPD flare-up, do not use Breo Ellipta as it is not intended for quick relief.
Breo Ellipta is a once-daily medication that helps to improve lung function for a full 24 hours. It is important to use Breo Ellipta as prescribed by your doctor and to discuss rescue treatment options with them. In addition, it is crucial to keep all medicines, including Breo Ellipta, out of the reach of children and never share your medicines with others.
While Breo Ellipta can help manage symptoms and reduce the frequency of flare-ups, it is not meant to be a rescue inhaler for sudden breathing difficulties. It is important to have a separate rescue inhaler prescribed by your doctor to treat sudden asthma or COPD attacks. This rescue inhaler should be used as directed by your doctor to provide quick relief during emergencies.
Breo Ellipta is a maintenance medication that should be taken daily to effectively manage asthma or COPD symptoms. It is not designed to provide immediate relief during an asthma or COPD attack. Therefore, it is important to understand that Breo Ellipta is not a rescue medicine and should be used as a preventative measure to control symptoms and improve overall lung function.
Kinesio Tape: Friend or Foe for Muscle Pain?
You may want to see also
Explore related products
It is used to treat asthma and COPD
The Breo Ellipta inhaler is a prescription medicine used to treat asthma and chronic obstructive pulmonary disease (COPD). It is a combination of two medicines: fluticasone furoate, an inhaled corticosteroid (ICS), and vilanterol trifenatate, a long-acting beta2-adrenergic agonist (LABA).
Fluticasone furoate helps to reduce inflammation in the lungs, while vilanterol trifenatate relaxes the muscles around the airways, making it easier to breathe. This combination of medications helps to improve breathing and reduce flare-ups in people with COPD and asthma.
Breo Ellipta is not a rescue inhaler and should not be used to treat sudden, severe symptoms of COPD or asthma. It is meant to be used daily to prevent and manage symptoms. For sudden flare-ups or asthma attacks, fast-acting rescue inhalers should be used.
Breo Ellipta is approved for use in adults and children aged 5 years and older with asthma. For COPD, it is used to treat chronic bronchitis, emphysema, or both, helping to improve symptoms and reduce flare-ups. It is important to use Breo Ellipta exactly as prescribed by a doctor and to follow the directions on the prescription label.
Iron Deficiency and Muscle Weakness: What's the Link?
You may want to see also
Explore related products
It can cause side effects like a sore throat
The Breo Ellipta inhaler is a combination of two medications: fluticasone, an inhaled corticosteroid, and vilanterol, a long-acting beta agonist. It is used to treat chronic obstructive pulmonary disease (COPD) and asthma by relaxing the muscles in the airways to improve breathing.
Breo Ellipta can cause side effects, including a sore throat, irritation, and hoarseness. These side effects are due to the active ingredient, such as a corticosteroid, depositing on the back of the throat. The risk of experiencing a sore throat can be reduced by using a spacer device, rinsing your mouth with water after each dose, and improving your inhaler technique.
Breo Ellipta may also cause other side effects, such as upper respiratory tract infections, headaches, oral thrush, and a weakened immune system. It is important to consult a doctor or healthcare provider if you experience any side effects, as they may advise adjusting your treatment plan or dosage.
Additionally, it is worth noting that Breo Ellipta is not meant to be used as a rescue inhaler for sudden flare-ups or severe symptoms of COPD or asthma. Instead, it is meant to be used daily to prevent and manage symptoms.
Muscle Relaxers: Do They Cause Night Sweats?
You may want to see also
Explore related products
It should not be used with similar inhaled medicines
Breo Ellipta is a prescription medicine used to treat asthma and chronic obstructive pulmonary disease (COPD). It is a combination of two medicines: an inhaled corticosteroid (ICS) called fluticasone furoate and a long-acting beta2-adrenergic agonist (LABA) called vilanterol. Fluticasone furoate helps to reduce inflammation in the lungs, while vilanterol relaxes the muscles around the airways, making it easier to breathe.
Breo Ellipta is not a rescue inhaler and should not be used to treat sudden flare-ups or exacerbations of symptoms. It is meant to be used daily to prevent and manage symptoms. If you are experiencing a sudden worsening of symptoms, such as an asthma attack or a COPD flare-up, do not use Breo Ellipta to treat these symptoms. Instead, you should use a rescue inhaler, such as albuterol, to treat the sudden attack.
Breo Ellipta should not be used with similar inhaled medicines, including other LABA medicines. This includes formoterol (found in Perforomist, Symbicort, Bevespi, Dulera), arformoterol (Brovana), indacaterol (Arcapta), olodaterol (Striverdi, Stiolto Respimat), salmeterol (Serevent), and vilanterol (Anoro Ellipta). Combining Breo Ellipta with these medicines may lead to serious side effects.
It is important to discuss your treatment options with your doctor and follow their instructions on how to take your medication. Your doctor may prescribe another medicine to be used in case of an acute attack or sudden flare-up. Always inform your doctor about all the medications you are taking, including prescription drugs, over-the-counter medicines, vitamins, and herbal supplements. This information will help your doctor determine if Breo Ellipta is safe for you and reduce the risk of any adverse reactions.
Muscle Milk and Kidney Stones: What's the Connection?
You may want to see also
Frequently asked questions
Breo Ellipta is a powder inhaler that contains fluticasone and vilanterol. Fluticasone is a steroid that prevents the release of substances in the body that cause inflammation, while vilanterol is a bronchodilator that works by relaxing muscles in the airways to improve breathing. While Breo Ellipta is not known to cause muscle jitters, it can cause muscle spasms in some cases.
The most common side effects of using the Breo Ellipta inhaler include upper respiratory tract infection, pneumonia, hoarseness, back pain, thrush in the mouth and throat, flu, muscle spasms, urinary tract infection, cough, inflammation of the sinuses, and diarrhea. It is important to note that these side effects may vary depending on age and dosage.
If you experience any side effects from using the Breo Ellipta inhaler, it is important to consult your healthcare provider immediately. They can help determine if your treatment plan needs to be adjusted or if alternative medications are necessary. It is also recommended to regularly monitor your progress with your doctor to ensure the medication is working properly and to check for any unwanted effects.
